Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2021 / Mar / Baby One More Time
Anterior Segment Cornea Research & Innovations

Baby One More Time

Could a better understanding of HSV triggers prevent future outbreaks?

By Phoebe Harkin 3/11/2021 1 min read

Share

Herpes simplex virus (HSV) is not a “one and done” disease. It hides in the body, waiting to strike again. This process is known as reactivation – typically associated with periods of stress, illness, or sunburn – and, left untreated, can result in blindness. But what exactly causes this reactivation? The answer: neuronal hyperexcitation. Researchers at the University of Virginia School of Medicine have discovered that the virus hijacks an important immune response: when exposed to prolonged periods of inflammation or stress, the immune system releases interleukin 1 beta (IL-1β), a cytokine present in epithelial cells of the skin and eye and released when those cells are damaged by ultraviolet light. IL-1β increases affected neurons’ excitability, setting the stage for HSV reactivation. Though further studies are needed to fully understand these factors – and establish how they can be used to develop potential therapeutics – the team hope their insights will shed new light on the immune system and, ultimately, help prevent HSV outbreaks.

References

  1. S Cuddy et al., ELife, 2, 58037 (2020). PMID: 33350386.

About the Author(s)

Phoebe Harkin

I’ve always loved telling stories. So much so, I decided to make a job of it. I finished a Masters in Magazine Journalism and spent three years working as a creative copywriter before itchy feet sent me (back)packing. It took seven months and 13 countries, but I’m now happily settled on The Ophthalmologist, where I’m busy getting stuck into all things eyeballs.

More Articles by Phoebe Harkin

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: